Asthma, Eczema, Cardiac conditions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Must have an established diagnosis of asthma, atopic dermatitis or eczema, or a cardiac condition requiring long-term Warfarin therapy (e.g., atrial fibrillation, cardiac valve-related condition/replacement, post-Fontan operation). 2. Must be receiving the treatment of interest (inhaled corticosteroids for asthma, any topical treatment for atopic dermatitis or eczema, or Warfarin therapy for a cardiac condition), in KKH. 3. Must be aged 10 to 20 years 4. Singapore Citizen or Singapore Permanent Resident 5. Able to communicate in English 6. The participant must provide consent to be interviewed at least three times: the first interview will be conducted face-to-face, and the subsequent interviews will be at three months and six months, which may be face-to-face or via phone calls, depending on the participant's preference. 7. The participant must provide consent for the interviews to be audio-recorded.
Exclusion criteria
Exclusion criteria: 1. The participant has a plan to move overseas within the next six months. 2. The participant has an unfavorable prognosis with a life expectancy of less than 24 months. 3. The participant is involved in other research or clinical trials that could interfere with the study's data collection or analysis. 4. The participant has significant cognitive or communication impairments that would hinder effective participation in interviews or the informed consent process.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As this is a supporting treatment adherence study, the primary outcomes are how well the participants follow the treatment plan and associated advice as directed by their doctors (and other healthcare professionals). For appropriate asthma inhaler use, this would be achieved via Medication Possession Ratio, Proportion of Days Covered, Medication Implementation/Adherence Questionnaires, medical record review, etc. For other advice this would be achieved depending on the nature of the advice, for example removal of pets by asking family members/home visit/proxy interviews, shortening of bath time by digital timer, laundry care and allergen control by home visit and purchase proof, food photograph and random checks, etc. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heath-related Quality of Life, Step-up therapy (e.g. via GINA steps review from medical records), Hospitalization and emergency department visit, Qualitative interviews on treatment adherence, Patients' and Providers' evaluation of the intervention/support/tools/education materials, Surveillance, cost analysis, and HTA. | — |
Countries
Asia(except Japan)
Contacts
KK Women's and Children's Hospital, SingHealth Duke-NUS, Singapore Department of Paediatrics